Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
Michael Shapiro, President of American Society for Preventive Cardiology (ASPC), shared Carlos Andrés Vergara Sánchez‘s post on LinkedIn, adding:
“Grateful to Carlos Andrés Vergara Sánchez for the generous words. Seeing fellows and early-career colleagues engage deeply in preventive cardiology is exactly why we launched these efforts.
At the American Society for Preventive Cardiology (ASPC), we are committed to creating real pathways for trainees who want to build careers in prevention.
The ASPC Training Academy and the AJPC Academy are two examples of how we are investing in mentorship, scholarship, and leadership development.
If you are interested in preventive cardiology, I encourage you to get involved. The future of the field depends on you.
Khurram Nasir and Carlos Andrés Vergara Sánchez, thank you for your leadership and partnership.”
Carlos Andrés Vergara Sánchez, Chief Cardiovascular Disease Fellow at Mayo Clinic College of Medicine and Science, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“The American Journal of Preventive Cardiology and American Society for Preventive Cardiology are investing in the future of academic preventive cardiology.
Under the leadership of Dr Michael Shapiro and Dr Khurram Nasir, their commitment to supporting trainees and early-career physicians has never been more tangible — all in service of better science and better patient care.
I’ve had the privilege of witnessing firsthand the energy and intention behind this effort.
The AJPC Academy is turning vision into opportunity for colleagues across the country.
Honored to be part of this incredible initiative.
Read more in the new publication”
Tilte: AJPC academy: A four-pillar model for cultivating the next generation of academic leaders in cardiovascular prevention
Authors: Carlos Vergara Sanchez, Ramzi Dudum, Michael D. Shapiro, Khurram Nasir
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026
-
Jul 12, 2026, 15:45Nathan Connell: Key Clinical Advances in Heavy Menstrual Bleeding and Postpartum Hemorrhage from ISTH 2026
-
Jul 12, 2026, 15:40Anne-Claire Duchez: Join Us at ISTH 2026 to Discover Our Latest Research and Meet the Team
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1